General MedicationsINJECTIONGeneric
DALGAN
DEZOCINE
Standard Dose
5MG/ML
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary
Approval overview DALGAN is listed in Drugs@FDA under application 019082 (NDA).
Marketing status: Discontinued Active ingredient DEZOCINE Form and strength INJECTABLE;INJECTION - 5MG/ML Sponsor ASTRAZENECA Submission history See approval history documents.
Structured Monograph
Clinical summary
Approval overview DALGAN is listed in Drugs@FDA under application 019082 (NDA). Marketing status: Discontinued Active ingredient DEZOCINE Form and strength INJECTABLE;INJECTION - 5MG/ML Sponsor ASTRAZENECA Submission history See approval history documents.
Monitoring
- • Marketing status: Discontinued
Interaction Notes
- No interaction notes stored yet.